Hikma Raises Expectations For 2021 After A Host Of Launches

Expects Uptick For Advair Rival In H2 As Vascepa Generic Gradually Gains Share

 
• By Dave Wallace
  
Wooden Blocks 2021 Up Arrow
Hikma has raised its full-year forecast for 2021 • Source: Alamy

More from Earnings

More from Business